No image available for this title

LITERATURE

Cilostazol Has Beneficial Effects in Treatment of Intermittent Claudication :Results From a Multicenter, randomized, Prospective


Cilostazol is a new phosphodiesterase inhibitor that suppresses platelet aggregation and also acts as a direct
arterial vasodilator. This prospective, randomized, placebo-controlled, parallel-group clinical trial evaluated the efficacy
of cilostazol for treatment of stable, moderately severe intermittent claudication


Availability

Antiplat-02Titan CenterAvailable

Detail Information

Series Title
-
Call Number
-
Publisher : .,
Collation
-
Language
English
ISBN/ISSN
-
Classification
NONE
Content Type
-
Media Type
-
Carrier Type
-
Edition
-
Subject(s)
Specific Detail Info
Circulation 1998;98;678-686
Statement of Responsibility

Other version/related

No other version available


File Attachment



Information


RECORD DETAIL


Back To Previous